Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PKM | P14618 | 1/20 | 0.55 |
| ▸ | ATM | Q13315 | 2/20 | 0.54 |
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.48 |
| ▸ | MAPT | P10636 | 1/20 | 0.48 |
| ▸ | HPGD | P15428 | 1/20 | 0.48 |
| ▸ | HTT | P42858 | 1/20 | 0.48 |
| ▸ | CACNA1B | Q00975 | 1/20 | 0.48 |
| ▸ | APBA1 | Q02410 | 1/20 | 0.48 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.48 |
| ▸ | CASP1 | P29466 | 2/20 | 0.46 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.45 |
| ▸ | PPARD | Q03181 | 1/20 | 0.40 |
| ▸ | PPARA | Q07869 | 1/20 | 0.40 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.39 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.39 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.39 |
| ▸ | APP | P05067 | 1/20 | 0.39 |
| ▸ | LMNA | P02545 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25849173 | 0.86 | TDP1 (0.44) | PKMALDH1A1CASP1TDP1PPARD | |
| SCHEMBL25849155 | 0.80 | PKM (0.51) | PKMATMALDH1A1MAPTCASP1 | |
| SCHEMBL304176 | 0.74 | TDP1 (0.78) | ALDH1A1MAPTCASP1TDP1MAPK1 | |
| SCHEMBL25849170 | 0.73 | PKM (0.49) | PKMATMALDH1A1MAPTCASP1 | |
| Bicarbonate SCHEMBL7699565 | 0.73 | TDP1 (0.75) | ALDH1A1MAPTCASP1TDP1MAPK1 | |
| SCHEMBL28207503 | 0.73 | TDP1 (0.75) | ALDH1A1MAPTCASP1TDP1MAPK1 | |
| Ammonia Solution, Strong SCHEMBL28588274 | 0.73 | TDP1 (0.75) | ALDH1A1MAPTCASP1TDP1MAPK1 | |
| SCHEMBL6159752 | 0.72 | TDP1 (0.64) | ALDH1A1CASP1TDP1MAPK1L3MBTL1 | |
| SCHEMBL305392 | 0.72 | TDP1 (0.68) | ALDH1A1CASP1TDP1MAPK1L3MBTL1 | |
| SCHEMBL29551592 | 0.72 | ALDH1A1 (0.60) | ALDH1A1MAPTTDP1SMN1; SMN2LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230203474-A1 | COMPOUND, SOLID CARRIER INCLUDING THE SAME AND METHOD FOR PREPARING NUCLEIC ACID | INDUSTRIAL TECHNOLOGY RESEARCH INSTITUTE (TW) | 2023-06-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230203474-A1 | COMPOUND, SOLID CARRIER INCLUDING THE SAME AND METHOD FOR PREPARING NUCLEIC ACID | SNRPA, NSUN2, POLRMT | PKM 1412/4885ATM 1598/4885ALDH1A1 2601/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.